Human Molecular Genetics, 2002, Vol. 11, No. 23 2905-2917
© 2002 Oxford University Press
Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells
1Graduate School of Medicine, University of Tennessee Medical Center, 1924 Alcoa Highway, Knoxville TN 37920, USA and 2Division of Biology, University of Tennessee, M303 Walters Life Sciences, Knoxville TN 37996, USA
Received July 8, 2002; Accepted August 27, 2002
A number of observations point to the aggregation of expanded polyglutamine [poly(Q)]-containing proteins as playing a central role in the etiology of Huntington's disease (HD) and other expanded CAG-repeat diseases. Transfected cell and transgenic animal models provide some of this support, but irrefutable data on the cytotoxicity of poly(Q) aggregates is lacking. This may be due in part to difficulties in observing all aggregated states in these models, and in part to the inability to conclusively rule out the role of monomeric states of the poly(Q) protein. To address these questions, we produced aggregates of simple poly(Q) peptides in vitro and introduced them to mammalian cells in culture. We find that Cos-7 and PC-12 cells in culture readily take up aggregates of chemically synthesized poly(Q) peptides. Simple poly(Q) aggregates are localized to the cytoplasm and have little impact on cell viability. Aggregates of poly(Q) peptides containing a nuclear localization signal, however, are localized to nuclei and lead to dramatic cell death. Amyloid fibrils of a non-poly(Q) peptide are non-toxic, whether localized to the cytoplasm or nucleus. Nuclear localization of an aggregate of a short, Q20, poly(Q) peptide is just as toxic as that of a long poly(Q) peptide, supporting the notion that the influence of poly(Q) repeat length on disease risk and age of onset is at the level of aggregation efficiency. The results support a direct role for poly(Q) aggregates in HD-related neurotoxicity.
* To whom correspondence should be addressed. Tel: +1 8655449168; Fax: +1 8655449235; Email: rwetzel{at}mc.utmck.edu
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Raspe, J. Gillis, H. Krol, S. Krom, K. Bosch, H. van Veen, and E. Reits Mimicking proteasomal release of polyglutamine peptides initiates aggregation and toxicity J. Cell Sci., September 15, 2009; 122(18): 3262 - 3271. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nekooki-Machida, M. Kurosawa, N. Nukina, K. Ito, T. Oda, and M. Tanaka Distinct conformations of in vitro and in vivo amyloids of huntingtin-exon1 show different cytotoxicity PNAS, June 16, 2009; 106(24): 9679 - 9684. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Frost, R. L. Jacks, and M. I. Diamond Propagation of Tau Misfolding from the Outside to the Inside of a Cell J. Biol. Chem., May 8, 2009; 284(19): 12845 - 12852. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Pellistri, M. Bucciantini, A. Relini, D. Nosi, A. Gliozzi, M. Robello, and M. Stefani Nonspecific Interaction of Prefibrillar Amyloid Aggregates with Glutamatergic Receptors Results in Ca2+ Increase in Primary Neuronal Cells J. Biol. Chem., October 31, 2008; 283(44): 29950 - 29960. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Southwell, A. Khoshnan, D. E. Dunn, C. W. Bugg, D. C. Lo, and P. H. Patterson Intrabodies Binding the Proline-Rich Domains of Mutant Huntingtin Increase Its Turnover and Reduce Neurotoxicity J. Neurosci., September 3, 2008; 28(36): 9013 - 9020. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Stefani Generic Cell Dysfunction in Neurodegenerative Disorders: Role of Surfaces in Early Protein Misfolding, Aggregation, and Aggregate Cytotoxicity Neuroscientist, October 1, 2007; 13(5): 519 - 531. [Abstract] [PDF] |
||||
![]() |
Y. Takahashi, Y. Okamoto, H. A. Popiel, N. Fujikake, T. Toda, M. Kinjo, and Y. Nagai Detection of Polyglutamine Protein Oligomers in Cells by Fluorescence Correlation Spectroscopy J. Biol. Chem., August 17, 2007; 282(33): 24039 - 24048. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Scappini, T.-W. Koh, N. P. Martin, and J. P. O'Bryan Intersectin enhances huntingtin aggregation and neurodegeneration through activation of c-Jun-NH2-terminal kinase Hum. Mol. Genet., August 1, 2007; 16(15): 1862 - 1871. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Duennwald, S. Jagadish, P. J. Muchowski, and S. Lindquist Flanking sequences profoundly alter polyglutamine toxicity in yeast PNAS, July 18, 2006; 103(29): 11045 - 11050. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. A. Desai, J. Pallos, A. A. K. Ma, B. R. Stockwell, L. M. Thompson, J. L. Marsh, and M. I. Diamond Biologically active molecules that reduce polyglutamine aggregation and toxicity Hum. Mol. Genet., July 1, 2006; 15(13): 2114 - 2124. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Ellisdon, B. Thomas, and S. P. Bottomley The Two-stage Pathway of Ataxin-3 Fibrillogenesis Involves a Polyglutamine-independent Step J. Biol. Chem., June 23, 2006; 281(25): 16888 - 16896. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Pieri, M. Bucciantini, D. Nosi, L. Formigli, J. Savistchenko, R. Melki, and M. Stefani The Yeast Prion Ure2p Native-like Assemblies Are Toxic to Mammalian Cells Regardless of Their Aggregation State J. Biol. Chem., June 2, 2006; 281(22): 15337 - 15344. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Bett, G. M. Goellner, B. Woodman, G. Pratt, M. Rechsteiner, and G. P. Bates Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REG{gamma} as a therapeutic target Hum. Mol. Genet., January 1, 2006; 15(1): 33 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Poirier, H. Jiang, and C. A. Ross A structure-based analysis of huntingtin mutant polyglutamine aggregation and toxicity: evidence for a compact beta-sheet structure Hum. Mol. Genet., March 15, 2005; 14(6): 765 - 774. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, D. L. Smith, A. B. Meriin, S. Engemann, D. E. Russel, M. Roark, S. L. Washington, M. M. Maxwell, J. L. Marsh, L. M. Thompson, et al. A potent small molecule inhibits polyglutamine aggregation in Huntington's disease neurons and suppresses neurodegeneration in vivo PNAS, January 18, 2005; 102(3): 892 - 897. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Helmlinger, J. Bonnet, J.-L. Mandel, Y. Trottier, and D. Devys Hsp70 and Hsp40 Chaperones Do Not Modulate Retinal Phenotype in SCA7 Mice J. Biol. Chem., December 31, 2004; 279(53): 55969 - 55977. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Everett and N. W. Wood Trinucleotide repeats and neurodegenerative disease Brain, November 1, 2004; 127(11): 2385 - 2405. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-C. Zeng, S. Bhasin, X. Wu, J.-G. Lee, S. Maffi, C. J. Nichols, K. J. Lee, J. P. Taylor, L. E. Greene, and E. Eisenberg Hsp70 dynamics in vivo: effect of heat shock and protein aggregation J. Cell Sci., October 1, 2004; 117(21): 4991 - 5000. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Schilling, A. V. Savonenko, A. Klevytska, J. L. Morton, S. M. Tucker, M. Poirier, A. Gale, N. Chan, V. Gonzales, H. H. Slunt, et al. Nuclear-targeting of mutant huntingtin fragments produces Huntington's disease-like phenotypes in transgenic mice Hum. Mol. Genet., August 1, 2004; 13(15): 1599 - 1610. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bucciantini, G. Calloni, F. Chiti, L. Formigli, D. Nosi, C. M. Dobson, and M. Stefani Prefibrillar Amyloid Protein Aggregates Share Common Features of Cytotoxicity J. Biol. Chem., July 23, 2004; 279(30): 31374 - 31382. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Rousseau, B. Dehay, L. Ben-Haiem, Y. Trottier, M. Morange, and A. Bertolotti Targeting expression of expanded polyglutamine proteins to the endoplasmic reticulum or mitochondria prevents their aggregation PNAS, June 29, 2004; 101(26): 9648 - 9653. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Busch, S. Engemann, R. Lurz, H. Okazawa, H. Lehrach, and E. E. Wanker Mutant Huntingtin Promotes the Fibrillogenesis of Wild-type Huntingtin: A POTENTIAL MECHANISM FOR LOSS OF HUNTINGTIN FUNCTION IN HUNTINGTON'S DISEASE J. Biol. Chem., October 17, 2003; 278(42): 41452 - 41461. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Michalik and C. Van Broeckhoven Pathogenesis of polyglutamine disorders: aggregation revisited Hum. Mol. Genet., October 15, 2003; 12(90002): R173 - 186. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Mandrusiak, L. K. Beitel, X. Wang, T. C. Scanlon, E. Chevalier-Larsen, D. E. Merry, and M. A. Trifiro Transglutaminase potentiates ligand-dependent proteasome dysfunction induced by polyglutamine-expanded androgen receptor Hum. Mol. Genet., July 1, 2003; 12(13): 1497 - 1506. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.J. Cowan, M.I. Diamond, and W.J. Welch Polyglutamine protein aggregation and toxicity are linked to the cellular stress response Hum. Mol. Genet., June 15, 2003; 12(12): 1377 - 1391. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Ross, M. A. Poirier, E. E. Wanker, and M. Amzel Polyglutamine fibrillogenesis: The pathway unfolds PNAS, January 7, 2003; 100(1): 1 - 3. [Full Text] [PDF] |
||||
![]() |
A. K. Thakur and R. Wetzel Mutational analysis of the structural organization of polyglutamine aggregates PNAS, December 24, 2002; 99(26): 17014 - 17019. [Abstract] [Full Text] [PDF] |
||||






